SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 29.22 |
Enterprise Value ($M) | 19.13 |
Book Value ($M) | 8.44 |
Book Value / Share | 0.53 |
Price / Book | 3.46 |
NCAV ($M) | 8.43 |
NCAV / Share | 0.53 |
Price / NCAV | 3.47 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -2.53 |
Return on Assets (ROA) | -0.67 |
Return on Equity (ROE) | -0.74 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 4.23 |
Current Ratio | 4.23 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 11.04 |
Assets | 11.05 |
Liabilities | 2.61 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -25.07 |
Net Income | -23.96 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -21.05 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Deep Track Capital, LP | 9.89 | ||
13G/A | Affinity Asset Advisors, LLC | 2.06 | -62.79 | |
13G/A | Lehr Martin A. | 8.80 | ||
13G | Opaleye Management Inc. | 5.14 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
40,240 | 37,863 | 106.28 | |
178,920 | 112,291 | 159.34 | |
15,370 | 22,623 | 67.94 | |
98,418 | 61,189 | 160.84 | |
46,399 | 78,644 | 59.00 | |
(click for more detail) |
Similar Companies | |
---|---|
CLVR – Clever Leaves Holdings Inc. | CMPX – Compass Therapeutics, Inc. |
CNSP – CNS Pharmaceuticals, Inc. | COCP – Cocrystal Pharma, Inc. |
COEP – Coeptis Therapeutics Holdings, Inc. |
Financial data and stock pages provided by
Fintel.io